Navigation Links
Third European Novel Food Approval Received by Tahitian Noni International
Date:4/28/2010

Outnumbered only by Unilever, TNI and Danone share the leading position in the European Union’s “Novel Foods” category

Provo, UT (Vocus) April 28, 2010 -- Tahitian Noni International (TNI) received the company’s third Novel Food approval from the European Commission on Food Safety. Now, not only do noni juice and noni leaf have Novel Food approval, but also noni concentrates and noni puree have authorization to be sold within the European Union. In terms of the total number of Novel Food approvals, Tahitian Noni International shares an equal number with Danone and is outnumbered only by the five individual approvals granted to the Unilever Group.

Committed to Science and Quality from Day One
Approval procedures for Novel Foods take time, money, and require significant scientific research assuring the safety of the product in question. It is not uncommon for an application to take five years or more being reviewed, before approval is granted.

Kevin Asay, Tahitian Noni International’s Managing Director in charge of Regulatory Affairs and Quality Assurance, says: “14 years after the founding of our company, we are in a position to compete with Danone in the category of approved Novel Food applications. We take pride in this achievement and are confident that it stems from our commitment to science and quality from day one.”

Noni is now a Full-Fledged Novel Food
With this third approval, Tahitian Noni International now holds Novel Food approval for all food categories relevant to their wide variety of products. In 2003, the first approval was issued for the use of noni juice as a novel food ingredient in Tahitian Noni™ Original, then marketed as Tahitian Noni™ Juice in Europe. This approval was followed in 2008 by the authorization of noni leaves as a novel food ingredient for the preparation of other products, including tea. This latest approval now gives Tahitian Noni International the ability to use noni concentrates and noni puree in products as well.

Currently, Tahitian Noni International is focused on the worldwide product launch of its new product line of Tahitian Noni® Bioactive Beverages™ introduced in the USA at the end of February 2010. A graduated launch in Europe is scheduled to start at the end of May 2010.

About the Company
Tahitian Noni International is a global, research-driven bioactive products company that was the first to introduce the health benefits of the noni plant—a bioactive-rich, adaptogenic plant, containing iridoid compounds—to the world outside of Tahiti. Tahitian Noni International is the leader in the discovery, development, manufacturing, and marketing of noni-based bioactive products including beverages, beauty, and weight loss lines. Tahitian Noni International has a presence in over 70 markets worldwide, and is the world-wide leader in bioactive beverages.

Contact:
Andre Peterson
Director, Public Relations
(801) 234-1401

# # #

Read the full story at http://www.prweb.com/releases/2010/Novel_food_approval/prweb3934514.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. SIS Rules-Based Charging Solution Successfully Peer Reviewed by HFMA for Third Consecutive Year
2. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010
3. Anthem Blue Cross Wins Third Largest Medicaid Managed Care Contract Renewal in the Country
4. Tipping Point Community Announces $1 Million Gift at Third Annual Awards Breakfast
5. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
6. Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work
7. Two-Thirds of American Teens Need More Shut-Eye
8. Study Finds More Than One Third of Parents Experience Traumatic Stress One Month After Childs Injury
9. New Program Provides COBRA Relief for Third Party Administrators
10. Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results
11. New Study Shows Nearly One Third of Overweight Adolescents See Themselves as Underweight or About Right
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Third European Novel Food Approval Received by Tahitian Noni International 
(Date:5/27/2016)... ... ... More than a third of American adults are considered obese, says the ... increased attention in recent years, as an article published May 18th on ... people are familiar with the basic requirements of maintaining a healthy diet and exercise ...
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... care world, this installment is bolstered by inspiring human interest stories, courtesy of ... the developing trends and tech within the industry, from leading advocates and associations—namely ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research ... their dogs straight off the grill. Of the 90 percent of Americans who say ... a hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its Connor Cares ... the Tamika Catchings Legacy Tour that will commemorate the Indiana Fever legend’s ... surfaces in all forms and levels of the game, Connor Sports has committed to ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... study highlights the necessity of health literacy within the technology advancement of diagnostic imaging. According ... , a majority of oncology patients undergo imaging screenings without understanding the nuanced risks ... ... ... Medical Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... , May 27, 2016 ... biopharmaceutical company focused on late-stage drug development, today ... Pharma of pivotal batches required for registration ... Administration (FDA). This follows Kitov,s announcement ... trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
Breaking Medicine Technology: